Navigation Links
Croissance Clinical Research Collaborates with Acceliant for Clinical Trial Excellence
Date:1/8/2014

BANGALORE, India, January 8, 2014 /PRNewswire/ --

Acceliant, a global technology provider of innovative clinical trial data management solutions, stated that Croissance Clinical Research, a full-fledged CRO providing services for pharmaceutical, bio-technology and medical devices companies, has preferred to choose Acceliant's eClinical Suite to aid their clinical trial data management. Acceliant's integrated e-PRO/EDC system offers a superior solution by allowing complete study data to be readily available and eliminating the integration costs.

     (Logo: http://photos.prnewswire.com/prnh/20130627/625230)

Satish Marukurthi, CEO, Croissance Clinical Research, said on this partnership, "Acceliant is our partner of choice based on their proven track record of accomplishments and expertise. We evaluated Acceliant eClinical Suite as being superior to other products in terms of driving efficiency and accelerating clinical trial studies. I believe that leveraging on Acceliant's knowledge and expertise will prove to be immensely beneficial for us in raising the standards of clinical trial efficiency."

Sri Manchala, CEO, Acceliant, commented, "Our integrated EDC-ePRO platform with innovative workflows and built-in mobility which allows data management from anywhere, anytime is designed to keep up with the everchangingever-changing needs of the life sciences industry. Our collaboration with Croissance Clinical Research strengthens our clientele and helps us differentiate ourselves in this highly competitive marketplace."

"Keeping up with our accelerated growth in India, we are proud to partner with Croissance Clinical Research.  We look forward to a successful long-term relationship aiding them in clinical trial management. This partnership strengthens our commitment to provide unparalleled services in the space of clinical trial management solutions," said Santhosh S. Nagaraj, Sales Head, Acceliant.

About Croissance Clinical Research

Croissance Clinical Research is a full service CRO, providing services to pharmaceutical, biotechnology and medical devices companies. At Croissance Clinical Research stalwarts of the Pharmaceutical and Clinical Research Industry have come together integrating their decades of knowledge and experiences to develop an optimized system for Clinical Research Industry. We apply our innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. Specialties include Clinical Trial Operations, Site Management, Clinical Data Management, Biostatistics, Medical Writing and Quality Assurance

About Acceliant

Acceliant is the medical industry technology division of Trianz, a global technology services and solutions company. A pioneer in the EDC industry, Acceliant has been providing solutions in the clinical trial management space since 1999. The company caters to the needs of the pharmaceutical, biotechnology, medical device, CRO, and non-profit drug research industries. Acceliant has helped facilitate clinical data management in hundreds of trials worldwide encompassing dozens of therapeutic areas for global giants as well as emerging healthcare innovators.

Prashant Bhavaraju
CMO
info@acceliant.com
+1-408-387-5899


'/>"/>
SOURCE Trianz
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MNX nomme un nouveau membre à son conseil dadministration, la société vise à accélérer sa croissance dans la logistique pour les domaines pharmaceutique et des essais cliniques
2. BioSpecifics Technologies Corp. Announces Positive Top-line Data from Phase 2 Clinical Trial of CCH for the Treatment of Human Lipoma
3. Data Sciences International acquires Buxco Research Company to expand preclinical research solutions offering
4. Clinical Trial Participation Today May Lead To Future Breakthroughs In Pancreatic Cancer, One Of The Nations Deadliest Cancers
5. TauRx Expands Alzheimers Clinical Trials in the United States
6. ideaPoint, Inc. Announces Launch of Multi-Sponsor Portal Providing Researchers Opportunity to Request Access to Clinical Data from Five Global Study Sponsors
7. Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
8. CMC Biologics and OncoSynergy Enter into Agreement to Develop and Manufacture Material for IND Enabling Studies and Phase I Clinical Trials
9. Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health
10. Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America
11. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):